Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Astria Therapeutics, Inc.Listing unverified | Buy | $30M | conv 65Unusual size | SEC | |
Solid Biosciences Inc.Listing on record | Buy | $18.9M | conv 68First in 12mo | SEC | |
Landos Biopharma, Inc.Listing unverified | BuyD (derivative) | $14.7M | First in 12mo | SEC | |
Landos Biopharma, Inc.Listing unverified | BuyD (derivative) | $2M | First in 12mo | SEC |